Pulmonx
Minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.
Launch date
Employees
Market cap
$325m
Enterprise valuation
$267m (Public information from Sep 2024)
Share price
$8.58 LUNG
Redwood City California (HQ)
Authorizing premium user...